monocrotaline has been researched along with Anorexia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albuquerque, B; Chen, X; Hirenallur-Shanthappa, D; Sheikh, A; Stansfield, JC; Wu, Z; Zhang, BB; Zhao, Y | 1 |
| Booth, FW; Lees, SJ; Steffen, BT | 1 |
2 other study(ies) available for monocrotaline and Anorexia
| Article | Year |
|---|---|
Neutralization of GDF15 Prevents Anorexia and Weight Loss in the Monocrotaline-Induced Cardiac Cachexia Rat Model.
Topics: Animals; Anorexia; Antibodies, Monoclonal; Cachexia; Growth Differentiation Factor 15; Humans; Monocrotaline; Rats; Weight Loss | 2022 |
Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia.
Topics: Animals; Anorexia; Blotting, Western; Body Weight; Cachexia; Eating; Enzyme-Linked Immunosorbent Assay; Gene Expression; Heart Diseases; Male; Monocrotaline; Muscle, Skeletal; Organ Size; Pentoxifylline; Poisons; Rats; Rats, Sprague-Dawley; Receptors, Tumor Necrosis Factor, Type I; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Tumor Necrosis Factor Inhibitors; Ubiquitin; Weight Loss | 2008 |